Search filters

List of works by Miki Ohira

A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines

scientific article published on December 23, 2012

ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity

scientific article published on July 14, 2011

Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature

scientific article

Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification

scientific article published on 18 August 2010

Oncogenic LMO3 Collaborates with HEN2 to Enhance Neuroblastoma Cell Growth through Transactivation of Mash1

scientific article published on May 5, 2011

Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers

scientific article published on 17 September 2014

Specific mitochondrial DNA mutation in mice regulates diabetes and lymphoma development

scientific article published on June 11, 2012

Stronger Prognostic Power of the CpG Island Methylator Phenotype than Methylation of Individual Genes in Neuroblastomas

scientific article published on April 25, 2013

Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties

scientific article published on 30 January 2020

Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma

scientific article published on January 29, 2013